Fujifilm
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
Also, Fujifilm is reorganising its Medical Systems business units.
Also, Augnito unveils its ambient technology for clinical documentation.
Also, South Korean researchers have built an AI model for predicting the side effects of immunotherapy on a patient.
Also, Roche and Astellas have combined their diabetes management solutions.
The National Institute on Aging will utilize Ro's telehealth platform to screen and recruit patients at elevated risk for developing Alzheimer's disease or other related dementia.
Fujifilm Thailand supports this implementation using Microsoft Azure.
Two variants of the Annalise CXR Edge products will be offered in Australia.
A clinical trial has shown that it can predict AD progression with 88% and 84% accuracy in American and Japanese patients, respectively.
The diagnostic software runs on Lunit's AI technology to spot major abnormal findings.